Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05022147 · ClinicalTrials.gov registry record · Phase 1
Enhancing Gait Using Alternating-Frequency DBS in Parkinson Disease
A Phase 1 study of Parkinson Disease and Deep Brain Stimulation, sponsored by James Liao.
- Active
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT05022147 is a Phase 1 study of Parkinson Disease and Deep Brain Stimulation that is active but no longer recruiting, run by James Liao. The registered enrollment target is 12 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05022147, a Phase 1 study of Parkinson Disease and Deep Brain Stimulation, is active but no longer recruiting, sponsored by James Liao.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess how alternating-frequency Deep Brain Stimulation (DBS) works to improve postural instability and gait, while also treating other motor symptoms of Parkinson Disease (PD).
Conditions Studied
Interventions
- DEVICE High-Frequency-Only Stimulation
- DEVICE Low-Frequency-Only Stimulation
- DEVICE Alternating, 50 sec High-Frequency, 10 sec Low-Frequency Stimulation
- DEVICE Alternating, 50 sec High-Frequency, 50 sec Low-Frequency Stimulation
- DEVICE Alternating, 10 sec High-Frequency, 50 sec Low-Frequency Stimulation
Study Locations (1)
Ohio
- Cleveland Clinic Foundation - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2021-10-04 |
| Est. Completion | 2026-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05022147
The ClinicalTrials.gov registry entry for NCT05022147 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The listed sponsor is James Liao, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 5 interventions - of which High-Frequency-Only Stimulation is the first listed.
NCT05022147 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05022147 about?
NCT05022147 is a clinical study titled "Enhancing Gait Using Alternating-Frequency DBS in Parkinson Disease". The purpose of this study is to assess how alternating-frequency Deep Brain Stimulation (DBS) works to improve postural instability and gait, while also treating other motor symptoms of Parkinson Disease (PD).
What is the current status of trial NCT05022147?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2021-10-04. Estimated completion is 2026-05.
What conditions does trial NCT05022147 study?
This clinical trial studies the following conditions: Parkinson Disease, Deep Brain Stimulation, Accidental Fall, Gait Disorders, Neurologic, Disease Progression.
What interventions are being tested in trial NCT05022147?
The interventions under investigation include: High-Frequency-Only Stimulation (DEVICE), Low-Frequency-Only Stimulation (DEVICE), Alternating, 50 sec High-Frequency, 10 sec Low-Frequency Stimulation (DEVICE), Alternating, 50 sec High-Frequency, 50 sec Low-Frequency Stimulation (DEVICE), Alternating, 10 sec High-Frequency, 50 sec Low-Frequency Stimulation (DEVICE).
Who is sponsoring clinical trial NCT05022147?
This trial is sponsored by James Liao, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05022147 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
RECRUITING · Phase 1
-
Treating Parkinson's Disease Through Transplantation of Autologous Stem Cell-Derived Dopaminergic Neurons
RECRUITING · Phase 1
-
First-in-Human Single and Multiple Dose of HL-400
RECRUITING · Phase 1
-
Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments
RECRUITING · Phase 1
-
[18F]F-DOPA Imaging in Patients With Autonomic Failure
RECRUITING · Phase 1
-
A Study to Assess the Safety of BMS-984923 Compared to Placebo, in People With Parkinson's
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.